News

Whether you’ve been diagnosed with depression, an anxiety disorder or simply want to talk to a professional about the issues ...
Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...
Sarepta's gene therapy pipeline faces renewed scrutiny after a third patient death and FDA plans for a black box warning on ...
This commentary is by Alex LeClair of Essex, CFO of LeClair Therapy Inc., DBA Essex Physical Therapy & Georgia Physical Therapy.
The Purdy family shares their insights on navigating their child’s rare neurodegenerative disease and their direct ...
Why Benedict Cumberbatch Is Calling Out Hollywood for Being a "Grossly Wasteful Industry" ...
Sarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy ...
Sarepta Therapeutics refuses the FDA request to halt its gene therapy shipments following a third patient death, challenging ...
Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing ...
The biotech says sales of its first commercial therapy, Ryoncil, were $20 million in the quarter ending June 30.
For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...